INVO FERTILITY INC

IVFNASDAQ

🏆 #3982 by market capEarnings Aug 13US Equity

$1.03▼ $0.01 (−0.96%)

🌙 After hours$1.06▲ 2.91%Regular close · extended-hours price shown

1h—

24h▼ 1.0%

7d—

14d—

30d—

1y—

🏦Market Cap

$2M

Small Cap

📈Revenue Growth (YoY)

+9.5%

Slowing

📊Gross Margin

36.9%

Healthy

💵FCF Margin

0.2%

Thin

⚖️P/S Ratio

0.3x

Cheap

Otter Score

Weak

No chart data available for IVF.

Trading Snapshot

Day Range: $1.03 – $1.04
52-Week Range: $0.90 – $84.40
Volume: $3.58B
Avg Volume: $4.65B
Shares Outstanding: 2.3M
Next Earnings: Sep 3, 2026

Fundamentals Snapshot

Annual Revenue: $7M
Last Q Revenue: $2M
P/E Ratio: —
P/S Ratio: 0.3x
EPS (TTM): $-560.19
Dividend Yield: —

Why Investors Own IVF

✓High-growth profile — revenue up +55.0% YoY with expanding US Equity exposure.
✓Healthy economics — 77% gross margin and 21% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$7M▲ +54.5% YoY

Gross Margin (TTM)

76.8%▲ +3.7% YoY

Operating Income (TTM)

$1M▲ +54.5% YoY

Free Cash Flow (TTM)

$1M▲ +54.5% YoY

About INVO FERTILITY INC

INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.

🦦